Succinate-producing microbiota drives tuft cell hyperplasia to protect against Clostridioides difficile https://t.co/l9oUzylGI1
Check out our recent publication from the Program in Microbiome Dynamics! #microbiome#UMassChan
UMass Chan Medical School seeks the next generation of scientific leaders! Join our research community as a UMass Chan Early Independence Fellow. Get 3-5 years of support. Apply by Dec 1: https://t.co/sE7mgqecWT @UMassChan@RTI_UMassChan
UMassChan Department of Microbiology MD/PhD student Ben Sallis in the McCormick lab presented his work in a poster at FASEB Gastrointestinal Tract XXI: Life, Death, and Disease on September 9th, 2024!
So fun giving the commencement address at @UMassChan (med school) celebrating these impressive doctors, nurses & scientists! (You may call me “Dr. Katie.”) Thanks for the feedback—my speech will be in Wake-Up Call tomorrow! Sign up at https://t.co/7FB4S3P56Q 🎓🩻🩺🥼
A poignant and very entertaining talk by the Distinguished Research Award winner Dr. Beth “Bugs” McCormick at the @APSPhysiology GI & Liver Section Banquet. Such a deserving recipient! 👏👏
Adiso Therapeutics Provides Development Update Reflecting Strong Progress Across Its Pipeline https://t.co/ZK7az7wDlk
It's a privilege for me to share this exciting news from Adiso! A great company backed by a great team!! Way to go!! @Adiso@UMassChan@Inflammation@IBD
Diet-microbiome interactions are complex! Check out our article in Gut Microbes to learn about first steps in detangling the impact of specific foods on bacterial species commonly depleted in patients with IBD to better inform dietary treatment @almaldonxx https://t.co/aRDh4ncKN6
Our Program in Microbiome Dynamics at @UMassChan https://t.co/SeYvhwprnG home of the UMass Center for Microbiome Research is looking for a Senior Scientific Writer to join our team. Here is the job posting: https://t.co/b62cUBpr0E
Apply!!!
Morningside Ventures Launches Adiso Therapeutics to Advance Novel Therapies for Inflammatory Diseases https://t.co/iVGhoVCMTP Happy to share we are out of stealth mode!!! #inflammation#IBD#ulcerativecolitis#Cdiff#UMassChan
#UMassChan researchers Evan S. Bradley, MD, PhD, & John P. Haran, MD, PhD, have found a clear biological signal associating a change in the oral microbiome w/ long-COVID symptoms. Read about their research: https://t.co/jrEqyMNhVn #COVID19#microbiome@JohnPHaran@UMass_Medicine
Bacainn Therapeutics Reports Positive Topline Results from Phase 1 Study of BT051, a Novel Therapeutic Approach to Treat Inflammatory Diseases Such As Ulcerative Colitis | Business Wire https://t.co/pv6Z8zgUmU